ライフサイエンスコーパス: flow-mediated dilation

1 cardiac effects of EECP on peripheral artery flow-mediated dilation.

2 ular endothelial function by brachial artery flow-mediated dilation.

3 Vascular reactivity was measured by flow-mediated dilation.

4 raditional CMV risk were not associated with flow-mediated dilation.

5 ia (20 min) and reperfusion, and measured by flow-mediated dilation.

6 found between diesel exhaust inhalation and flow-mediated dilation.

7 affeine (200 mg) had no short-term effect on flow-mediated dilation.

8 ial function in the brachial artery by using flow-mediated dilation.

9 ence of a threshold for the effect of SHS on flow-mediated dilation.

10 rease in endothelial function as measured by flow-mediated dilation.

11 25, p = 0.03) were independent predictors of flow-mediated dilation.

12 r reactivity was measured by brachial artery flow-mediated dilation.

13 g; P < 0.001) lower, the treatment effect on flow-mediated dilation [-0.62% (95% CI: -1.48%, 0.24%)]

14 ith HFpEF had more severe PED than controls: flow-mediated dilation 1.95% (-0.81 to 4.92) versus 5.02

15 inol associated with a trend toward improved flow-mediated dilation (+1.4% [3.9%] versus -0.7% [4.1%]

16 Brachial artery flow-mediated dilation, 24-hour urinary levels of 8-isop

17 (93 +/- 67% vs. 145 +/- 106%, p = 0.006) and flow-mediated dilation (4.2 +/- 1.8% vs. 5.4 +/- 1.7%, p

18 2 before ischemia prevented this decrease in flow-mediated dilation (5.9 +/- 0.7% vs. 5.2 +/- 0.5%, p

19 anakinra, there was a greater improvement of flow-mediated dilation (57+/-4% versus 47+/-5%), coronar

20 associated with a significant improvement in flow-mediated dilation (6.6+/-4.4% vs. 11.0+/-6.3%; P =

21 Placebo treatment produced no change in flow-mediated dilation (7.0+/-3.9% vs. 7.2+/-3.7%), wher

22 study, we observed improved brachial artery flow-mediated dilation (7.7 +/- 2.9% to 8.7 +/- 3.1%, P

23 is associated with impaired brachial artery flow-mediated dilation, a surrogate of endothelial dysfu

24 as change in maximal percent brachial artery flow-mediated dilation after exposure.

25 dysfunction (as evaluated by brachial artery flow-mediated dilation) after 8 hours.

26 with baseline diameter and the percentage of flow-mediated dilation, although these associations were

27 Secondary endpoints were change in flow-mediated dilation and augmentation index.

28 No correlation was found between changes in flow-mediated dilation and changes in low-density lipopr

29 dest unadjusted inverse correlations between flow-mediated dilation and CRP, IL-6, and sICAM-1 (P<0.0

30 Baseline flow-mediated dilation and endothelial progenitor cell l

31 has a beneficial effect on peripheral artery flow-mediated dilation and endothelial-derived vasoactiv

32 Indeed, both flow-mediated dilation and endothelium-dependent vasodil

33 continuous positive airway pressure therapy, flow-mediated dilation and expression of eNOS and phosph

34 ed to endothelial phenotype, as reflected by flow-mediated dilation and expression of P-selectin.

35 Women with hot flashes had reduced flow-mediated dilation and greater aortic calcification.

36 at women with hot flashes would show reduced flow-mediated dilation and greater coronary artery and a

37 ong inverse relation between brachial artery flow-mediated dilation and increasing quartile of serum

38 zyme-linked immunoassay, and brachial artery flow-mediated dilation and nitroglycerin-mediated dilati

39 influences brachial reactivity, we examined flow-mediated dilation and nitroglycerin-mediated dilati

40 as a significant inverse correlation between flow-mediated dilation and pulmonary vascular resistance

41 studied endothelium-dependent (posthyperemia flow-mediated dilation) and -independent (nitroglycerin)

42 dothelial function of conduit (radial artery flow-mediated dilation) and resistance vessels (blood fl

43 telomerase activity modulates microvascular flow-mediated dilation, and loss of telomerase activity

44 ial function was assessed as brachial artery flow-mediated dilation, and microvascular function was a

45 by forearm venous occlusion plethysmography, flow-mediated dilation, and pulse wave analysis.

46 eadmill walking performance, brachial artery flow-mediated dilation, and quality of life but did not

47 tion, normalized altered signaling pathways, flow-mediated dilation, and the increased oxidative stre

48 reatments in daytime ambulatory systolic BP, flow-mediated dilation, and total cholesterol/HDL choles

49 reased endothelium-dependent brachial artery flow-mediated dilation at 16 weeks, whereas placebo did

50 nge in endothelium-dependent brachial artery flow-mediated dilation at 16 weeks.

51 ase in blood flow (r=0.50, P=0.001) and with flow-mediated dilation at baseline (r=0.50, P=0.001).

52 inutes of forearm occlusion (Brachial Artery Flow Mediated Dilation = BAFMD) and a cold pressor test

53 Endothelial function was assessed by flow-mediated dilation before and after IR (20 minutes o

54 we measured ulnar artery flow, diameter, and flow-mediated dilation before and after removal of the a

55 vels, ROCK activity, C-reactive protein, and flow-mediated dilation before and after treatment.

56 ificant associations between hot flashes and flow-mediated dilation (beta=-0.97; SE, 0.44; P=0.03) an

57 hes were associated with significantly lower flow-mediated dilation (beta=-1.01; SE, 0.41; P=0.01) an

58 The difference in flow-mediated dilation between the top and bottom fifths

59 strong inverse correlation between ADMA and flow-mediated dilation but only in the group of women wh

60 Salsalate increased brachial artery flow-mediated dilation by 74% (from 4.0+/-0.4% to 6.6+/-

61 Low birth weight was associated with reduced flow-mediated dilation (coefficient=0.18 kg(-1), 95% CI

62 lipoprotein cholesterol, and brachial artery flow-mediated dilation compared with lean subjects (p <

63 When a flow-mediated dilation cutpoint of 8.1% was used, endoth

64 Peak flow-mediated dilation decreased by 43% after ischemia-r

65 Brachial artery flow-mediated dilation, digital pulse amplitude tonometr

66 1), nor was there an effect of L-arginine on flow-mediated dilation during hyperemia (3.8 +/- 3.0% vs

67 usion of vitamin C increased brachial artery flow-mediated dilation during placebo (P<0.001) but not

68 luded a brachial artery ultrasound to assess flow-mediated dilation, electron beam tomography to asse

69 During each trial, brachial artery flow mediated dilation (FMD) was used to assess endothel

70 exercise training on radial artery L-FMC and flow-mediated dilation (FMD) after transradial catheteri

71 Flow-mediated dilation (FMD) after upper arm occlusion w

72 and short-term air pollutant exposures with flow-mediated dilation (FMD) and baseline arterial diame

73 he association between brachial NO-dependent flow-mediated dilation (FMD) and cardiovascular disease

74 control subjects we examined brachial artery flow-mediated dilation (FMD) and circulating micropartic

75 Endothelium-dependent, flow-mediated dilation (FMD) and endothelium-independent

76 Brachial artery flow-mediated dilation (FMD) and nitroglycerin-mediated

77 the impact of blueberry flavonoid intake on flow-mediated dilation (FMD) and polyphenol absorption a

78 The relationship between impaired brachial flow-mediated dilation (FMD) and subsequent clinical car

79 stimate and compare endothelial function via flow-mediated dilation (FMD) assessment in periodontal h

80 nship between vascular wall shear stress and flow-mediated dilation (FMD) in humans, and 2) to invest

81 week 24 within-arm change in brachial artery flow-mediated dilation (FMD) in participants with comple

82 tors, we measured coronary vasomotion during flow-mediated dilation (FMD) in response to adenosine, c

83 s assessed by vascular ultrasound to measure flow-mediated dilation (FMD) in response to forearm reac

84 Endothelial function was assessed by flow-mediated dilation (FMD) in the brachial artery in r

85 Flow-mediated dilation (FMD) increased significantly aft

86 Flow-mediated dilation (FMD) of coronary arterioles was

87 Flow-mediated dilation (FMD) of the brachial artery and

88 pulmonary endothelial function, assessed by flow-mediated dilation (FMD) of the brachial artery and

89 Endothelial function was assessed by flow-mediated dilation (FMD) of the brachial artery pree

90 ) diet for 6 months on endothelium-dependent flow-mediated dilation (FMD) of the brachial artery were

91 e, estimated glomerular filtration rate, and flow-mediated dilation (FMD) of the brachial artery were

92 Flow-mediated dilation (FMD) of the brachial artery, a m

93 ging (MRI), assessed endothelial function by flow-mediated dilation (FMD) of the brachial artery, and

94 Changes in endothelial function, measured as flow-mediated dilation (FMD) of the brachial artery, has

95 determine whether smoking cessation improves flow-mediated dilation (FMD) of the brachial artery.

96 n was examined by measuring ischemia-induced flow-mediated dilation (FMD) of the brachial artery.

97 Although brachial artery flow-mediated dilation (FMD) predicts recurrent cardiova

98 aim was to determine reproducibility of the flow-mediated dilation (FMD) response profile, and discr

99 Endothelial function was assessed as flow-mediated dilation (FMD) using ultrasound.

100 al artery ultrasound, endothelium-dependent, flow-mediated dilation (FMD) was assessed in patients wi

101 Brachial artery flow-mediated dilation (FMD) was determined by B-mode ul

102 ted from a forearm vein, and brachial artery flow-mediated dilation (FMD) was measured before and 24

103 ed by mathematical modeling; brachial artery flow-mediated dilation (FMD) was measured before and aft

104 Preoperative endothelium-dependent flow-mediated dilation (FMD) was significantly lower in

105 Flow-mediated dilation (FMD), although the established t

106 s by CMR, changes in endothelial function by flow-mediated dilation (FMD), and arterial stiffness by

107 files, brachial artery endothelial-dependent flow-mediated dilation (FMD), and flow-independent nitro

108 The primary outcome was a change in flow-mediated dilation (FMD), and secondary outcomes wer

109 c pulse wave velocity (PWV), brachial artery flow-mediated dilation (FMD), and serum inflammatory mar

110 ure of endothelial function, brachial artery flow-mediated dilation (FMD), expressed as both percent

111 l artery measures, including brachial artery flow-mediated dilation (FMD), has not been well establis

112 Arterial stiffness, flow-mediated dilation (FMD), nitroglycerin-mediated dil

113 preoperative vascular function tests (VFTs): flow-mediated dilation (FMD), nitroglycerin-mediated dil

114 At baseline and after 6 wk of intervention, flow-mediated dilation (FMD), soluble vascular adhesion

115 Brachial artery flow-mediated dilation (FMD), urinary 8-isoprostaglandin

116 ction assessed by reactive hyperemia-induced flow-mediated dilation (FMD).

117 systemic macrovascular function by means of flow-mediated dilation (FMD).

118 exed by direct assessment of brachial artery flow-mediated dilation (FMD).

119 onic vessel wall tracking of brachial artery flow-mediated dilation (FMD).

120 l artery endothelial function as measured by flow-mediated dilation (FMD).

121 and vascular function using brachial artery flow-mediated dilation (FMD).

122 id-artery intimal media thickness (cIMT) and flow-mediated dilation (FMD).

123 e and after brachial artery occlusion [i.e., flow-mediated dilation (FMD)] and before and after nitro

124 Brachial artery flow-mediated dilation (FMD, endothelium dependent) and

125 n ultrasound images were used to measure the flow-mediated dilation (FMD; endothelium dependent) and

126 Flow-mediated-dilation (FMD) was also performed.

127 - 30 mmol/day), and conduit (brachial artery flow-mediated dilation [FMD(BA)]) and resistance (forear

128 ion to brachial artery vasodilator function (flow-mediated dilation [FMD] and reactive hyperemia) ass

129 nction in the systemic arterial circulation (flow-mediated dilation [FMD] in the brachial artery) and

130 Endothelial function (brachial artery flow-mediated dilation [FMD]) was measured at baseline,

131 nd points included change in brachial artery flow-mediated dilation (FMDBA) and aortic pulse-wave vel

132 The primary outcome was the change in flow-mediated dilation from pre- to postintervention.

133 centile, absence of carotid plaque, brachial flow-mediated dilation >5% change, ankle-brachial index

134 t increment (0.623 vs 0.784), while brachial flow-mediated dilation had the least (0.623 vs 0.639).

135 ia thickness, ankle-brachial index, brachial flow-mediated dilation, high-sensitivity C-reactive prot

136 Flow-mediated dilation improved from 6.6+/-3.5% to 10.1+

137 Brachial artery flow-mediated dilation improved on all therapies (all P<

138 tion ultrasound to determine brachial artery flow-mediated dilation in 50 pediatric heart transplant

139 olidine carboxylate (OTC) on EDNO-dependent, flow-mediated dilation in a randomized double-blind plac

140 ; nitric oxide synthase inhibitor) abolished flow-mediated dilation in arterioles from subjects witho

141 IR caused a significant reduction in flow-mediated dilation in healthy volunteers (baseline,

142 type 5 cGMP phosphodiesterase inhibitor, on flow-mediated dilation in heart failure is unknown.

143 Flow-mediated dilation in patients with cardiovascular d

144 Heart rate, blood pressure, flow-mediated dilation in the brachial artery, and carot

145 Impaired flow-mediated dilation in vivo correlated with increased

146 3-glucoside supplementation had no effect on flow-mediated dilation, insulin resistance, or other CVD

147 Ultrasound assessment of brachial artery flow-mediated dilation is emerging as a useful clinical

148 Flow-mediated dilation is less variable than PWA.

149 Flow-mediated dilation, low-flow-mediated constriction,

150 HT had significant impairment of flow-mediated dilation (mean vasodilation 5+/-6%; P=0.01

151 nally increased endothelial function (higher flow-mediated dilation: mean 8.2 +/- 3.2% vs. 8.1 +/- 3.

152 Flow-mediated dilation measured by B-ED is robust and pr

153 artery endothelial function was assessed by flow-mediated dilation (n = 25 patients) at baseline and

154 age, 62 years) with measured brachial artery flow-mediated dilation (n=1446) or hyperemic flow veloci

155 The postischemic flow-mediated dilation of brachial artery decreased from

156 and 3 hours after treatment, we assessed (1) flow-mediated dilation of brachial artery; (2) coronary

157 The mechanism involves enhanced, flow-mediated dilation of stenotic epicardial conduit ve

158 ced collateral remodeling, angiogenesis, and flow-mediated dilation of the arterial bed supplying the

159 Flow-mediated dilation of the brachial and femoral arter

160 9 versus 18.6+/-6.7 micromol/L, P=0.546), on flow-mediated dilation of the brachial artery (11.9+/-6.

161 Flow-mediated dilation of the brachial artery (by ultras

162 sted endothelial function in all women using flow-mediated dilation of the brachial artery at 23-25 w

163 d) ascorbic acid treatment on EDNO-dependent flow-mediated dilation of the brachial artery in patient

164 Endothelial function was evaluated by flow-mediated dilation of the brachial artery in vivo an

165 Flow-mediated dilation of the brachial artery was 25% sm

166 Flow-mediated dilation of the brachial artery was measur

167 n patients with HFpEF.; METHODS AND RESULTS: Flow-mediated dilation of the brachial artery, matrix me

168 We assessed systemic (flow-mediated dilation of the brachial artery, pulse-wav

169 consumption improved endothelium- dependent flow-mediated dilation of the brachial artery, whereas c

170 In vivo flow-mediated dilation of the RA is comparable to that o

171 IR reduced flow-mediated dilation of the radial artery at 15 minute

172 No significant changes were seen in either flow-mediated dilation or augmentation index.

173 ween haplotypes (minimum P=0.002) and either flow-mediated dilation or hyperemic flow velocity.

174 low (OR, 1.23 [95% CI, 1.04-1.46]) and lower flow-mediated dilation (OR, 0.80 [95% CI, 0.67-0.96]) du

175 Flow-mediated dilation (p < 0.001) and PWA with salbutam

176 tin 40 mg reduced ROCK activity and improved flow-mediated dilation (P<0.01 for both compared with ba

177 surgery (P=0.05), and lower brachial artery flow-mediated dilation (P=0.007).

178 d HDL), endothelial function [as assessed by flow-mediated dilation, peripheral arterial tonometry/En

179 (P=0.01) and correlated with improvement in flow-mediated dilation (R(2)=-0.78, P<0.01).

180 soprostaglandin F2alpha (r=0.38; P=0.01) and flow-mediated dilation (r=-0.34; P=0.04).

181 betic patients and was associated with lower flow-mediated dilation (r=-0.541, P=0.02).

182 salsalate was inversely related to baseline flow-mediated dilation (r=-0.77, P<0.01).

183 ction in humans, we measured brachial artery flow-mediated dilation, reactive hyperemia, and serum co

184 I elevation was not considered an event, low flow-mediated dilation remained an independent predictor

185 Flow-mediated dilation remains the most reproducible met

186 Epicatechin supplementation did not change flow-mediated dilation significantly (1.1% absolute; 95%

187 Endothelial function, which was measured as flow-mediated dilation, significantly improved and was n

188 Flow-mediated dilation studies indicated no meaningful c

189 Selective loss of flow-mediated dilation suggests a role for fibrillin in

190 , applanation tonometry, and brachial artery flow-mediated dilation testing.

191 eloped pre-eclampsia had significantly lower flow-mediated dilation than did women who had normal out

192 se plasma BH4 and had a greater reduction of flow-mediated dilation than OO patients.

193 us +2%) and femoral (+30% versus +3%) artery flow-mediated dilation, the nitric oxide turnover/produc

194 For brachial artery flow-mediated dilation, those in the treadmill group had

195 Secondary outcomes were brachial artery flow-mediated dilation, treadmill walking performance, t

196 8.3 (1.4) mg/dl, respectively, and baseline flow-mediated dilation values (SDs) of 6.0% (5.0%) and 4

197 coronary artery calcium was 0.659, brachial flow-mediated dilation was 0.024, ankle-brachial index w

198 er long-term treatment (9.0+/-3.7%), whereas flow-mediated dilation was 8.6+/-4.7% at baseline and re

199 In 19 healthy subjects, flow-mediated dilation was assessed before and after who

200 Flow-mediated dilation was examined by high-resolution v

201 Brachial artery flow-mediated dilation was examined with high-resolution

202 Flow-mediated dilation was highly predictive for CAD wit

203 Flow-mediated dilation was inversely related to arterial

204 Flow-mediated dilation was inversely related to baseline

205 Flow-mediated dilation was linearly proportional to hype

206 n, in isolated pressurized carotid arteries, flow-mediated dilation was markedly reduced in Cav-1 KO

207 Flow-mediated dilation was measured at baseline and 4 h

208 Flow-mediated dilation was measured in vessels pretreate

209 ssociated with exercise systolic BP, whereas flow-mediated dilation was negatively associated (P<0.00

210 Flow-mediated dilation was negatively associated with L5

211 Flow-mediated dilation was reduced at 15 minutes of reco

212 the absolute maximal percent brachial artery flow-mediated dilation was reduced by 0.67%.

213 Flow-mediated dilation was reduced by IR (8.7 +/- 1.1% b

214 Flow-mediated dilation was significantly impaired in pat

215 Flow-mediated dilation was significantly lower in black

216 Preoperative endothelium-dependent flow-mediated dilation was significantly lower in patien

217 Peak flow-mediated dilation was similar, but the duration of

218 EDD (brachial artery flow-mediated dilation) was approximately 50% lower in o

219 achial artery reactivity, using postischemic flow-mediated dilation, was also measured.

220 For flow-mediated dilation, we found no evidence that inflam

221 Baseline arterial diameter and percentage of flow-mediated dilation were measured by ultrasound.

222 Carotid intima-media thickness and brachial flow-mediated dilation were not associated with incident

223 Protein expression and flow-mediated dilation were not significantly affected b

224 endothelial assessment using brachial artery flow-mediated dilation were obtained at baseline and at

225 pression of eNOS and phosphorylated eNOS and flow-mediated dilation were significantly lower, whereas

226 ssibility that assessment of brachial artery flow-mediated dilation will be useful in the management

227 The change in brachial artery flow-mediated dilation with salsalate was inversely rela